In case of interest to folk here. https://www.investegate.co.uk/immupharma-plc--imm-/rns/completion-of-lupuzort-pivotal-phase-iii-study/201801180700072020C/ ImmuPharma PLC (LSE:IMM), the specialist...
https://clinicaltrials.gov/ct2/show/NCT02504645?term=immupharma&rank=1 United States, California WALLACE Recruiting Los Angeles, California, United States Contact: Daniel WALLACE 310-360-9197...
Anyone up to speed with this? ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to provide a further update on the progress...
Hope 2016 is a landmark year for Lupus drug trials and research. Merry Xmas. Congress Increases Funding for Lupus in 2016 Last night, Congress unveiled its Consolidated Appropriations Act (H.R. 2029)...
http://www.immupharma.org/interviews The phase 3 trial has now opened in the US. Principle investigator is Daniel Wallace - one of the World's leading experts on Lupus....
The clinical study is titled "A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care...
Finally some good news one hopes. I don't know how you would get on a trial nor where it's being done, but in Europe most likely (France or UK?) Link to Lupuzor http://www.immupharma.org/lupuzor 30...
Hi, I've been lurking at the Lupus forum for a while. Not easy reading, which I guess is nothing compared to what many endure. The reason for posting is I keep an eye on the research in this area...